Clinical trial

HDR Brachytherapy, EBRT and STAD for the Treatment of Prostate Cancer

NCT03553602

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2017-12-20

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2017-12-20Date precision: day

Registry last updated2026-01-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancer - Recurrentunresolved

Interventions

HDR Brachytherapy + EBRT + STADDRUG

Sponsors & collaborators

Loyola Universitylead sponsor

Mapped research locations

MaywoodIllinois, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03553602 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.